NR667 WEEK 8 EXIT EXAM FINAL TEST PAPER
2026 FULL QUESTIONS AND SOLUTIONS
VERIFIED A+
◉ Final diagnosis: Obesity. Answer: -Perform focused history and
physical exam to evaluate for obesity complications and
comorbidities
-None needed for dx, but can assist with identifying obesity-related
comorbidities: thyroid function, lipid panel, fasting glucose, A1C,
fasting insulin, LFTs, CBC, CMP, lipase, amylase, ECG, screening for
anxiety/depression and OSA
◉ Prevention: Obesity. Answer: -Well-balanced diet
-Reduce sedentary behavior, increase regular physical activity; goal
150 mins/week, including resistance exercise
-Sufficient sleep: inadequate sleep causes gherkin to increase and
leptin to decrease, producing greater hunger than when rested
◉ Non-pharm management: Obesity. Answer: -Counseling about
lifelong strategies with use of 5As of obesity: ask, assess, advise,
aggress, assist
-Behavioral interventions: realistic goal setting, education, health
outcomes, focus on progress
,-Determine caloric requirement for body weight, then institute a 500
cal/day deficit during weight loss
-Track food and activity
-Regular f/u for health outcomes, weight loss tracking, motivation,
and improvement of obesity-related complications
◉ Pharmacological management: Obesity. Answer: -May be helpful
as adjuvant therapy with lifestyle interventions for patients with
BMI > 30 or 27 with comorbidities
-If one option doesn't work, consider others
-D/c medications in patients who do not respond with weight loss of
at least 5% in 12 weeks
-Avoid in pregnancy
◉ Follow-up: Obesity. Answer: -Long-term, frequent f/u as for most
chronic conditions; this disease has a relapsing nature based on
physiology, so patients require close monitoring
-Surgical patients need long-term f/u with surgeon and primary care
to monitor weight loss and nutrition
-Annual labs as indicated by medication administration,
comorbidities, and annual needs
◉ Expected course: Obesity. Answer: -Chronic condition: rarely
cured but can be controlled
,-Long-term maintenance of weight loss difficult due to metabolic
adaptation
-Dependent on sustained patient motivation and circumstances
◉ Possible complications: Obesity. Answer: -Prediabetes
-Metabolic syndrome
-DM II
-Dyslipidemia
-Cancer
-Hypertension
-CVD
-Non-alcoholic fatty liver disease and steatohepatitis
-PCOS, infertility
-Male hypogonadism
-Respiratory disease, including asthma
-Osteoarthritis
-Urinary stress incontinence
-GERD
-Psychiatric disorders
-Increased mortality
-Cholelithiasis, esp. with rapid weight loss
-Thromboembolism
, -Decreased mobility
-Decreased exercise tolerance
-OSA
◉ Etiology: Allergic rhinitis. Answer: -Any substance or condition
that causes an IgE-mediated response characterized by rupture of
mast cells and release of histamines, leukotrienes, prostaglandins,
and other compounds
-Seasonal allergens: pollens from grass, trees, weeds
-Perennial allergens: mold, animal dander, dust mites, smoke
◉ Risk factors: Allergic rhinitis. Answer: -Family history
-Other topics diseases (asthma, atopic dermatitis, allergic
conjunctivitis, food allergy)
-Repeated exposure to the allergen
-Non-adherence to treatment
◉ Assessment findings: Allergic rhinitis. Answer: -DX is based on
h+p findings consistent with allergy-related cause; presence of one
or more of these symptoms: nasal congestion, rhinorrhea, itchy
nose, sneezing
-Conjunctival injection, watery eyes
-Pale, boggy nasal mucosa with congestion and clear rhinorrhea
2026 FULL QUESTIONS AND SOLUTIONS
VERIFIED A+
◉ Final diagnosis: Obesity. Answer: -Perform focused history and
physical exam to evaluate for obesity complications and
comorbidities
-None needed for dx, but can assist with identifying obesity-related
comorbidities: thyroid function, lipid panel, fasting glucose, A1C,
fasting insulin, LFTs, CBC, CMP, lipase, amylase, ECG, screening for
anxiety/depression and OSA
◉ Prevention: Obesity. Answer: -Well-balanced diet
-Reduce sedentary behavior, increase regular physical activity; goal
150 mins/week, including resistance exercise
-Sufficient sleep: inadequate sleep causes gherkin to increase and
leptin to decrease, producing greater hunger than when rested
◉ Non-pharm management: Obesity. Answer: -Counseling about
lifelong strategies with use of 5As of obesity: ask, assess, advise,
aggress, assist
-Behavioral interventions: realistic goal setting, education, health
outcomes, focus on progress
,-Determine caloric requirement for body weight, then institute a 500
cal/day deficit during weight loss
-Track food and activity
-Regular f/u for health outcomes, weight loss tracking, motivation,
and improvement of obesity-related complications
◉ Pharmacological management: Obesity. Answer: -May be helpful
as adjuvant therapy with lifestyle interventions for patients with
BMI > 30 or 27 with comorbidities
-If one option doesn't work, consider others
-D/c medications in patients who do not respond with weight loss of
at least 5% in 12 weeks
-Avoid in pregnancy
◉ Follow-up: Obesity. Answer: -Long-term, frequent f/u as for most
chronic conditions; this disease has a relapsing nature based on
physiology, so patients require close monitoring
-Surgical patients need long-term f/u with surgeon and primary care
to monitor weight loss and nutrition
-Annual labs as indicated by medication administration,
comorbidities, and annual needs
◉ Expected course: Obesity. Answer: -Chronic condition: rarely
cured but can be controlled
,-Long-term maintenance of weight loss difficult due to metabolic
adaptation
-Dependent on sustained patient motivation and circumstances
◉ Possible complications: Obesity. Answer: -Prediabetes
-Metabolic syndrome
-DM II
-Dyslipidemia
-Cancer
-Hypertension
-CVD
-Non-alcoholic fatty liver disease and steatohepatitis
-PCOS, infertility
-Male hypogonadism
-Respiratory disease, including asthma
-Osteoarthritis
-Urinary stress incontinence
-GERD
-Psychiatric disorders
-Increased mortality
-Cholelithiasis, esp. with rapid weight loss
-Thromboembolism
, -Decreased mobility
-Decreased exercise tolerance
-OSA
◉ Etiology: Allergic rhinitis. Answer: -Any substance or condition
that causes an IgE-mediated response characterized by rupture of
mast cells and release of histamines, leukotrienes, prostaglandins,
and other compounds
-Seasonal allergens: pollens from grass, trees, weeds
-Perennial allergens: mold, animal dander, dust mites, smoke
◉ Risk factors: Allergic rhinitis. Answer: -Family history
-Other topics diseases (asthma, atopic dermatitis, allergic
conjunctivitis, food allergy)
-Repeated exposure to the allergen
-Non-adherence to treatment
◉ Assessment findings: Allergic rhinitis. Answer: -DX is based on
h+p findings consistent with allergy-related cause; presence of one
or more of these symptoms: nasal congestion, rhinorrhea, itchy
nose, sneezing
-Conjunctival injection, watery eyes
-Pale, boggy nasal mucosa with congestion and clear rhinorrhea
